
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School and Departments of 2 Nutrition and 3 Epidemiology, Harvard School of Public Health, Boston, Massachusetts
Requests for reprints: Edward Giovannucci, Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115. Phone: 617-432-4648; Fax: 617-432-2435. E-mail: edward.giovannucci{at}channing.harvard.edu
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In this report, we examined cancer incidence and mortality rates for Black men compared with White men in the Health Professionals Follow-up Study (HPFS). Men in this cohort are all highly educated health professionals, with relatively uniformly high use of health care, and of relatively homogeneous demographic and lifestyle factors. Given that Blacks in general and in the HPFS cohort specifically have been documented to have low vitamin D levels (16), our first aim was to examine whether total cancer incidence and mortality rates differ between Blacks and Whites, and particularly for digestive system cancers, which have been most consistently linked to poor vitamin D status. Second, because of the marginal vitamin D status in Blacks, we examined whether they might more susceptible to these cancers if they had additional risk factors for hypovitaminosis D. Finally, we examined the potential contribution of specific medical, lifestyle, dietary, and hormonal factors other than vitamin D status as alternative explanations to any observed differences in cancer rates.
| Materials and Methods |
|---|
|
|
|---|
Variables
Self-administered semiquantitative food frequency questionnaires, described in detail previously (17), were given in 1986, 1990, 1994, and 1998. The questionnaires contained a list of about 130 food and beverage items, each with a specified commonly used unit or portion size, and an open-ended section for unlisted foods. The men reported how often, on average, over the past year, they typically consumed each item. In addition, they reported the brand of breakfast cereal, duration, frequency of use, and brand of
1,400 distinct multivitamin supplements, including specific supplements (such as vitamin A or D). We computed nutrient intakes by multiplying the consumption frequency of each unit of food by its nutrient content, based on composition values from U.S. Department of Agriculture sources, supplemented with other data. The mean correlation coefficients between intakes determined by two 1-week diet records and the dietary questionnaire among a sample of 127 cohort members were 0.65 for nutrients, 0.63 for specific foods, and 0.86 for alcohol (17-19). We did not have data on vitamin D from the dietary records so we could not make direct comparison to the food frequency questionnaire, but we have previously shown that men with intake
400 IU/d had on average 10.4 ng/mL higher 25(OH)vitamin D [25(OH)D] level than those with intakes <100 IU/d (P < 0.01; ref. 3).
We asked the men to report height and weight in 1986. In a substudy, the correlation between self-report and technicians' measurements was 0.97 for weight and 0.99 for height (20). In 1986 and every 2 years thereafter, participants reported the average time per week that they engaged in various specific activities during the past year and the number of flights climbed daily and walking pace. To generate the total leisure-time physical activity score, we summed activity-specific MET-hours/wk based on the report of these activities. In a substudy of 238 study participants, the correlation between the questionnaire assessment of vigorous activity with four 1-week diary records was 0.58; reported vigorous activity predicted resting heart rate (r = 0.45; ref. 21). Cigarette smoking, body weight, physical examinations, digital rectal examinations, colonoscopy/sigmoidoscopy, and prostate-specific antigen screening (beginning in 1994) were assessed every 2 years. The number of teeth was asked in 1986.
Ascertainment of Cancers and Cause of Death
We asked for written permission to acquire relevant medical records and pathology reports from men (or next of kin) who reported a cancer. The follow-up rate with respect to the incidence of cancer was 97% of the total potential person-years, and death follow-up rate was >98%. Approximately 90% of cases were confirmed by medical record review, and the remaining cases were confirmed with information from the participant or family member, or by death certificate. Cause of death was based on medical record review by study physicians and by death certificate alone only rarely when medical records were not obtainable.
Statistical Analysis
The 43,949 White and Black men accrued follow-up time (person-months) beginning on the month of return of the baseline questionnaire and ending on the month of diagnosis of cancer for incidence analyses (or month of death for the mortality analyses), month of death from other causes, or January 31, 2002, whichever came first. We used Cox modeling to control for multiple variables simultaneously and to compute hazard ratios which estimate relative risk (RR) and 95% confidence intervals (95% CI). Age was controlled for in 1-year increments and time period in 2-year intervals. The following covariables were included in the models: height, region, body mass index (BMI), physical activity, smoking history, alcohol, and, for dietary variables, quintiles of total calories, red meat, calcium, vitamin D, retinol, and total fruits and vegetables. Nutrients were energy-adjusted using residual analysis on the natural logarithm scale. In further analyses, we considered number of teeth (1986) as a surrogate of early life socioeconomic status, as race and socioeconomic status are strong determinants of tooth loss (22). We examined total cancer incidence, total cancer incidence excluding organ-confined prostate cancers because of their favorable prognosis, strong susceptibility to detection bias, and their high prevalence (accounting for about half of all non-skin cancers), and excluding all prostate cancers, which we already had shown to be more common in Blacks (16). We also considered as a group cancers of the digestive system (cancers of the oral cavity, esophagus, stomach, pancreas, colon, and rectum). We conducted parallel analyses for fatal cancer.
To assess whether Black men with other risk factors for hypovitaminosis D were at particularly high risk of cancer, we jointly classified men by race and possession of risk factors for vitamin D deficiency, outside of race, including residence in the northeastern United States, vitamin D intake <400 IU/d, BMI >25 kg/m2, and physical activity level (a marker of outdoor sun exposure) below the median. These factors were determined to predict vitamin D status previously based on a sample of 1,095 HPFS men for whom we had measured plasma 25(OH)D (3). These factors, as well as race, were determined to be independent predictors of plasma 25(OH)D level.
| Results |
|---|
|
|
|---|
-carotene, lycopene, lutein, and ß-cryptoxanthin were higher in Blacks than in Whites.4 Vitamin D intake (from supplements and dietary) did not differ substantially, but in a sample of men, circulating 25(OH)D levels were substantially lower in Black men (P < 0.0001; published previously, ref. 16). More Black men had a diagnosis of diabetes mellitus and high blood pressure, whereas high cholesterol diagnoses did not differ between groups. Blacks were more likely to suffer tooth loss than Whites. Use of the medical system seemed high and relatively similar in both groups. Black men reported more frequent physical and digital rectal examinations; sigmoidoscopy or colonoscopy procedures were slightly higher in Whites, and about 90% of Whites and Blacks had had a prostate-specific antigen test.
|
|
|
Although adult socioeconomic status and use of health care did not seem to differ appreciably between Blacks and Whites in this cohort, socioeconomic status could have differed earlier in life for Blacks and Whites. When adding tooth loss as a surrogate of early life socioeconomic status to the multivariable models, the results for total and digestive cancer incidence did not change, and the results for total cancer mortality (RR, 1.85; 95% CI, 1.37-2.50; P < 0.0001) and digestive cancer mortality (RR, 2.20; 95% CI, 1.33-3.64; P = 0.002) were only slightly attenuated.
Finally, we cross-classified men by race and frequency of other determinants of poor vitamin D status. For Whites, each additional risk factor from none to four increased monotonically risk of cancer, especially digestive cancer mortality (for Whites with four risk factors compared with zero risk factors, the multivariable RR for digestive cancer incidence was 1.49; 95% CI, 1.05-2.12). Because of the much smaller numbers of Black men, for the racial comparisons, we could only dichotomize at those with zero or one risk factor (low risk) and those with two, three, or four risk factors (high risk). Black men were at 2- to 3-fold higher risk of cancer, especially digestive system cancers, if their vitamin D status was poor (i.e.,
2 risk factors), but had similar risks to Whites if vitamin D status was relatively high (Table 4
). Among men who provided blood samples, the following were the mean plasma 25(OH)D levels (and % with deficient values defined here as <16 ng/mL) in each group: Whites (
1 risk factor), 25.8 ng/mL (6.8% deficient); Whites (
2 risk factor), 23.1 ng/mL (12.6% deficient); Blacks (
1 risk factor), 21.6 ng/mL (31.6% deficient); Blacks (
2 risk factor), 17.2 ng/mL (62.1% deficient). Even in Whites with all four risk factors for hypovitaminosis D, vitamin D status was relatively good [mean 25(OH)D = 18.8 ng/mL; 17% deficient] compared with Black men in general.
|
| Discussion |
|---|
|
|
|---|
We then sought to examine potential factors underlying this higher cancer risk, with an a priori focus on vitamin D. Previously in a subsample of this cohort (16), we have found low vitamin D levels in Blacks, results consistent with other studies (6-9, 11). The generally lower 25(OH)D in Blacks is a result mostly of a higher degree of skin melanin, which effectively filters UV-B radiation (23), although differences in metabolism could also contribute. The vast majority of the supply of vitamin D in individuals is generated by sun exposure. Lower intake of vitamin D may contribute somewhat to hypovitaminosis D, but vitamin D intakes in the Black men were comparable with those in White men (354 versus 365 IU/d) and were reasonably high in the context of current recommendations (200 IU for adults up to age 50 years, 400 IU for adults 50-70 years of age, and 600 IU for individuals
70 years).
Our findings are noteworthy in view of increasing evidence that hypovitaminosis D may increase cancer incidence and progression (12) and may perhaps even affect survival (24, 25). That low levels of vitamin D may account for higher prostate cancer (13), more aggressive prostate and breast cancer (14), and higher total cancer incidence and mortality (12) in Blacks has been hypothesized previously. Recently, an inverse association between regional solar UV-B radiation and mortality rate of breast, colon, rectum, esophageal, and gastric cancers was shown for Blacks in the United States (15). Of note, evidence suggests that incidence of digestive system malignancies may be particularly increased in the presence of hypovitaminosis D (3-5), and in our study, Blacks seemed to be at especially high risk for this group of cancers. Also supporting a role of vitamin D was that Blacks were at very high risk for these cancers if they concomitantly had other risk factors for low vitamin D status (based on region of residence, BMI, dietary vitamin D, and physical activity), but not if they had a relatively good vitamin D status. The prevalence of vitamin D deficiency was much lower in Whites, but as risk factors for vitamin D deficiency increased in Whites, the frequency of hypovitaminosis D increased, and cancer risk increased.
Vitamin D has been proposed to influence cancer risk through a number of mechanisms, such as effects of cell proliferation, differentiation, apoptosis, and angiogenesis (12). Mechanisms whereby cancers of the digestive system seem to be most susceptible are currently obscure. The numbers of individual gastrointestinal cancers were too low for us to examine them individually, but for the most common colorectal cancer, the results were generally similar to the overall results. For example, Blacks with few risk factors for hypovitaminosis D were not at appreciably higher risk of colorectal cancer incidence (RR, 0.71; 95% CI, 0.18-2.87), but Black men with additional risk factors for poorer vitamin D status had an increased risk (RR, 2.43; 95% CI, 1.32-4.46).
We did not find any differences among various other dietary and lifestyle factors strong enough to explain these marked differences in cancer incidence and mortality (see Table 1). Furthermore, in a sample of the HPFS, we previously examined a number of plasma hormone levels, including total testosterone, dihydrotestosterone, estradiol, androstenediol glucuronide, sex hormonebinding globulin, insulin-like growth factor-1 (IGF-1), and IGF binding protein-3 (16, 26). None differed significantly between races, except for a 13% lower IGF binding protein-3 in Blacks. Although lower IGF binding protein-3 may theoretically increase risk of some cancers, the literature has been inconsistent (27), and the magnitude of the difference is probably not sufficient to contribute to substantial differences in risk. Moreover, the IGF-1/IGF binding protein-3 ratio, which presumably should increase risk, was slightly higher in Whites. The higher risk of type 2 diabetes mellitus suggests a relative hyperinsulinemia in Blacks, which is consistent with the literature (28). BMI was only marginally higher in Blacks and physical activity levels slightly lower; thus, Blacks were at higher risk for insulin resistance even at the same BMI level as Whites. Hyperinsulinemia could contribute to the marked racial difference in cancer rates, but to date, evidence is only reasonably strong that hyperinsulinemia is a factor for colon cancer (about 10% of total cancer deaths in U.S. men; ref. 29). Moreover, if the difference in insulin levels accounted for the 2-fold higher cancer mortality in Blacks in our cohort, we would expect that obesity, the strongest determinant of insulin resistance, would be an extremely strong risk factor for cancer mortality; however, as in the literature (30), we found obesity to be a moderate risk factor, and BMI was a much weaker risk factor for total cancer mortality than was Black ancestry. Thus, hyperinsulinemia could potentially contribute to the higher risk of cancer incidence and mortality in Blacks but probably is not the dominant factor.
Our study has several strengths and limitations. The detailed lifestyle and dietary data allowed us to examine potential factors that could contribute to racial differences in cancer incidence and mortality. The study design was prospective, averting recall bias, and our follow-up rates were high and essentially complete for mortality. Our major limitation was the relatively small number of Blacks, which substantially reduced our power to examine specific cancer sites. Nonetheless, we had adequate power to examine total and digestive cancer incidence and mortality. In addition, we did not have details for treatments for all cancer sites. However, treatment differences alone were unlikely to entirely explain our results because cancer incidence rates were higher in Blacks, and Blacks did not have higher mortality from non-malignant causes. Our study was limited to men; thus, we cannot generalize to women, although Black women also seem to be at relatively high risk for cancer mortality (2). Finally, we cannot prove that vitamin D explains the differences in races but can only state that Blacks who are likely to have poorer vitamin D status seem to be at very high risk for digestive system cancers.
The use of self-identified race in epidemiologic could serve multiple purposes, some of which are controversial (31). Our analysis focused on dietary and potential modifiable lifestyle factors as potentially contributing to some apparent racial disparities in cancer incidence and mortality rates. Our findings suggest that race could be acting, in part, as a surrogate of factors that influence vitamin D status. Although using race to characterize vitamin D status is imperfect, self-description as "African-American" was the strongest predictor of hypovitaminosis D. In fact, even Whites with all four risk factors of low vitamin D (other than race) had a lower prevalence of hypovitaminosis D than did Blacks with zero or one additional risk factor (17.7% versus 31.6%, respectively), and Blacks with at least two additional risk factors had a very high prevalence of hypovitaminosis D (63.1%). The generally higher degree of melanin is of obvious importance, but some studies indicate the existence of racial differences in the metabolism of vitamin D (32-34).
In a group of Black male health professionals characterized by high socioeconomic status, high degree of medical knowledge, high use of screening tests, and adherence to a healthful lifestyle and dietary practice comparable with their White counterparts, a marked difference in cancer incidence and especially mortality was found. We identified only vitamin D deficiency as a potentially relevant factor. Our results do not prove that vitamin D status is the causal factor underlying high cancer rates in Blacks. Such a conclusion could be drawn more directly if after controlling perfectly for lifetime vitamin D status, the higher risk in Blacks disappeared. What we showed was the Blacks have much higher rates of hypovitaminosis D than Whites, particularly if they had additional risk factors for poor vitamin D status, and that the prevalence of hypovitaminosis D based on a combination of race and other vitamin D risk factors corresponded to risk of cancer incidence and mortality, particularly of digestive cancer mortality. If hypovitaminosis D is indeed a causal risk factor for cancer, Blacks would be expected to be at particularly high risk. Thus, our results of higher risk of cancers suspected a priori to be associated with hypovitaminosis D in Blacks, especially those with additional risk factors for poor vitamin D status, are noteworthy, and further study of this topic should be a high priority.
| Acknowledgments |
|---|
| Footnotes |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 5/ 3/06; revised 8/24/06; accepted 9/14/06.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. Lipworth, M. Rossi, J. K. McLaughlin, E. Negri, R. Talamini, F. Levi, S. Franceschi, and C. La Vecchia Dietary vitamin D and cancers of the oral cavity and esophagus Ann. Onc., June 1, 2009; (2009) mdp036v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Holick MrOs Is D-ficient J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1092 - 1093. [Full Text] [PDF] |
||||
![]() |
J. P Reis, E. D Michos, D. von Muhlen, and E. R Miller III Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease Am. J. Clinical Nutrition, December 1, 2008; 88(6): 1469 - 1477. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Holick Vitamin D and Sunlight: Strategies for Cancer Prevention and Other Health Benefits Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1548 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pilz, H. Dobnig, B. Winklhofer-Roob, G. Riedmuller, J. E. Fischer, U. Seelhorst, B. Wellnitz, B. O. Boehm, and W. Marz Low Serum Levels of 25-Hydroxyvitamin D Predict Fatal Cancer in Patients Referred to Coronary Angiography Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1228 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Qureshi, F. Laden, G. A. Colditz, and D. J. Hunter Geographic Variation and Risk of Skin Cancer in US Women: Differences Between Melanoma, Squamous Cell Carcinoma, and Basal Cell Carcinoma Arch Intern Med, March 10, 2008; 168(5): 501 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhou, R. S. Heist, and D. C. Christiani In Reply J. Clin. Oncol., December 1, 2007; 25(34): 5538 - 5539. [Full Text] [PDF] |
||||
![]() |
D. M. Freedman, A. C. Looker, S.-C. Chang, and B. I. Graubard Prospective Study of Serum Vitamin D and Cancer Mortality in the United States J Natl Cancer Inst, November 7, 2007; 99(21): 1594 - 1602. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |